|
[351] www.mercola.com/2002/apr/27/sv40.htm [352] Hursting, S.D., Slaga,T.J., Fischer, S.M., DiGiovanni, J. and Phtans, J. M., 1999. Mechanism-based cancer prevention approaches: targets, examples, and the use of transgenic mice. Journal of the National Cancer Institute , 35, 2031–2038. [353] Cheeseman, K.H. and Slater, T.F., 1993. Free Radicals in Medicine . Churchill Livingston. [354] Cheeseman, K.H. and Slater, T.F., 1993. Free Radicals in Medicine . Churchill Livingston. [355] Stewart, H.J., 1989. Clinical experience in the use of antioestrogen tamoxifen in the treatment of breast cancer. Proceedings of the Royal Society of Edinburgh , 95B, 231–237. [356] Miller, W. R., 1997. Aromatase inhibitors and breast cancer. Cancer Treatment Reviews , 23, 113–131. [357] Dao, T.L., Sinha, D.K., Nemato, T. and Patel, J., 1982. Effects of estrogens and progesterone on cellular replication of human breast tumours. Cancer Research , 42, 359–362. [358] Conte, P.P., Fraschini, G. and Dewinko, B., 1985. Estrogen induced expansion of the growth fraction in receptor negative human breast cancer. Journal of Steroid Biochemistry , 23, 1169–1172. [359] Miller, W.R. and Langdon, S.P., 1997. Hormonal, growth factor and cytokine control of breast cancer. In: Biology of Female Cancers , pp. 43–60. Langdon, S,P., Miller, W.R. and Berchuck, A. (editors). New York: CRC Press. [360] Miller, W.R., 1991. Oestrogens and breast cancer: biological considerations, British Medical Bulletin , 47, 470–483. [361] Yu, H. and Rohan, T., 2002. Role of the insulin-like growth factor family in cancer development and progression. J. Natl Cancer Inst , 92, 1472–1489. [362] Rose, Steven, with Mileusnic, Radmila, 1999. The Chemistry of Life . Fourth (revised) edition. Penguin Books. [363] Voet, Donald and Voet, Judith, 1995. Biochemistry . Second edition. John Wiley & Sons, Inc. [364] Jiang, Wen G., Matsumoto, Kunio and Nakamura, Toshikazu (editors), 2001, Growth Factors and their Receptors in Cancer Metastasis . Dordrecht: Kluwer Academic Publishers. [365] Yu, H. and Rohan, T., 2002. Role of the insulin-like growth factor family in cancer development and progression. J. Natl. Cancer Inst. , 92, 1472–1489. [366] Yu, H. and Rohan, T., 2002. Role of the insulin-like growth factor family in cancer development and progression. J. Natl. Cancer Inst. , 92, 1472–1489. [367] www.ucop.edu/srphome/bcrp/progressreport/abstracts/innov/3CB-0186.html — 357 —
|